Advertisement

The role of optical coherence tomography angiography in diagnosis of polypoidal choroidal vasculopathy

  • Louis W. Lim
  • Colin S. Tan
Letter to the Editor
  • 94 Downloads

Notes

Compliance with ethical standards

Conflict of interest

Dr. Lim has no conflicts of interest. Dr. Tan receives conference support from Bayer, Heidelberg Engineering and Novartis.

References

  1. 1.
    Demirel S, Yanık Ö, Nalcı H, Batıoğlu F, Özmert E (2017) The use of optical coherence tomography angiography in pachychoroid spectrum diseases: a concurrent comparison with dye angiography. Graefes Arch Clin Exp Ophthalmol 255:2317–2324CrossRefPubMedGoogle Scholar
  2. 2.
    Gallego-Pinazo R, Dolz-Marco R, Gómez-Ulla F, Mrejen S, Freund KB (2014) Pachychoroid diseases of the macula. Med Hypothesis Discov Innov Ophthalmol 3:111–115PubMedPubMedCentralGoogle Scholar
  3. 3.
    Dansingani KK, Balaratnasingam C, Klufas MA, Sarraf D, Freund KB (2015) Optical coherence tomography angiography of shallow irregular pigment epithelial detachments in pachychoroid spectrum disease. Am J Ophthalmol 160:1243–1254CrossRefPubMedGoogle Scholar
  4. 4.
    Tan CS (2017) The role of optical coherence tomography angiography in polypoidal choroidal vasculopathy. JAMA Ophthalmol 135(1):1316–1317CrossRefPubMedGoogle Scholar
  5. 5.
    Chi Y-T, Yang C-H, Cheng C-K (2017) Optical coherence tomography angiography for assessment of the 3-dimensional structures of polypoidal choroidal vasculopathy. JAMA Ophthalmol 135:1310–1316CrossRefPubMedGoogle Scholar
  6. 6.
    Kim JY, Kwon OW, Oh HS, Kim SH, You YS (2016) Optical coherence tomography angiography in patients with polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 254:1505–1510CrossRefPubMedGoogle Scholar
  7. 7.
    de Carlo TE, Kokame GT, Kaneko KN, Lian R, Lai JC, Wee R (2018) Sensitivity and specificity of detecting polypoidal choroidal vasculopathy with en face optical coherence tomography and optical coherence tomography angiography. Retina.  https://doi.org/10.1097/IAE.0000000000002139
  8. 8.
    Tan CS, Ngo WK, Chen JP, Tan NW, Lim TH, EVEREST Study Group (2015) EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomized controlled trail of polypoidal choroidal vasculopathy. Br J Ophthalmol 99:624–628CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Tan CS, Ngo WK, Lim LW, Tan NW, Lim TH, EVEREST Study Group (2016) EVEREST study report 3: diagnostic challenges of polypoidal choroidal vasculopathy. Lessons learnt from screening failures in the EVEREST study. Graefes Arch Clin Exp Ophthalmol 254:1923–1930CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Tan CS, Lim LW, Ngo WK, Lim TH, EVEREST Study Group (2018) EVEREST report 5: clinical outcomes and treatment response of polypoidal choroidal vasculopathy subtypes in a multicenter randomized controlled trail. Invest Ophthalmol Vis Sci 59:889–896CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.National Healthcare Group Eye InstituteTan Tock Seng HospitalSingaporeSingapore
  2. 2.Fundus Image Reading CenterNational Healthcare Group Eye InstituteSingaporeSingapore

Personalised recommendations